<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>3</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2004</Year>
        <Month>09</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Interferon-Gamma Gene Polymorphism in Iranian Patients with Multiple Sclerosis</title>
    <FirstPage>115</FirstPage>
    <LastPage>120</LastPage>
    <AuthorList>
      <Author>
        <FirstName></FirstName>
        <LastName>Maryam Izad</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Mohammad Vodjgani</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Mohammad Hossein Nicknam</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Jamshid Lotfi</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Davood Fathi</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
      <Author>
        <FirstName></FirstName>
        <LastName>Ali Akbar Amirzargar</LastName>
        <affiliation locale="en_US"></affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Interferon- gamma (IFN- &#x3B3;) is an important immune regulator and inflammatory cytokine which is implicated in the pathogenesis of multiple sclerosis (MS). A single nucleotide polymorphism, T to A, at position +874 in the first intron has previously been shown. This polymorphism is associated with IFN- &#x3B3; production level. To study the effect of this polymorphism on susceptibility to multiple sclerosis, we screened genomic DNA samples from clinically definite MS patients and their unaffected first-degree relatives as controls, using sequence-specific primers (PCR-SSP). The results indicated that MS patients showed a lower TT (21.2% vs. 30.3%) and higher AA (21.2% vs. 12.1%) genotypes compared to controls, although there were statistically no differences in the IFN- &#x3B3; genotype distribution between these two groups. Thus, our data indicate that there is no association between IFN- &#x3B3; +874 polymorphism and MS susceptibility or severity of the disease.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/77</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/77/77</pdf_url>
  </Article>
</Articles>
